Indegene Limited (BOM:544172)

Market Cap	137.92B
Revenue (ttm)	28.39B
Net Income (ttm)	4.07B
Shares Out	n/a
EPS (ttm)	17.02
PE Ratio	33.91
Forward PE	29.22
Dividend	2.00 (0.35%)
Ex-Dividend Date	Jun 13, 2025

Volume	21,716
Average Volume	303,270
Open	574.30
Previous Close	574.70
Day's Range	565.20 - 578.65
52-Week Range	485.15 - 736.60
Beta	n/a
RSI	46.10
Earnings Date	Jul 30, 2025

About Indegene

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technolo...

• Industry: Commercial Physical and Biological Research
• Founded: 1998
• Employees: 4,158
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544172

Financial Performance

In 2024, Indegene's revenue was 28.39 billion, an increase of 9.64% compared to the previous year's 25.90 billion. Earnings were 4.07 billion, an increase of 20.79%.